| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 46,420 | 46,480 | 16.04. | |
| 46,185 | 46,660 | 16.04. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 650,00 | 4 | |||
| 170,00 | 8 | |||
| 135,00 | 57 | |||
| 60,00 | 15 | |||
| 52,20 | 500 | |||
| 51,76 | 50 | |||
| 48,000 | 60 | |||
| 46,660 | 180 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 180 | 46,185 | |||
| 100 | 41,000 | |||
| 37 | 36,000 | |||
| 120 | 20,800 | |||
| 1.052 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.489 | 0,587 | 874 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:58 | 45,385 | 2 |
| 17:09:18 | 45,663 | 20 |
| 16:58:29 | 45,205 | 75 |
| 16:58:08 | 45,175 | 2 |
| 16:47:21 | 45,320 | 20 |
| 16:21:34 | 45,170 | 9 |
| 16:17:34 | 45,250 | 20 |
| 16:17:03 | 45,350 | 136 |
| 16:16:53 | 45,453 | 20 |
| 16:05:40 | 45,205 | 190 |
| 15:58:51 | 45,090 | 68 |
| 15:53:51 | 45,058 | 23 |
| 15:53:19 | 44,970 | 73 |
| 15:53:19 | 44,970 | 207 |
| 15:53:19 | 44,975 | 58 |
| 15:52:29 | 45,085 | 121 |
| 15:52:26 | 45,025 | 5 |
| 15:52:26 | 45,020 | 60 |
| 15:46:06 | 45,400 | 20 |
| 15:40:19 | 45,470 | 26 |
| Tagesumsatz Xetra | +0,190 +0,42 % | 3.452 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | BAG schafft volle Transparenz: Moderna und Novavax: Bund zahlte eine Milliarde für Impfstoffe | 16 | Schweizer Fernsehen | ||
| Mi | Moderna, Inc.: Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026 | 267 | ACCESS Newswire | CAMBRIDGE, MA / ACCESS Newswire / April 15, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, May 1,2026 to report its... ► Artikel lesen | |
| Mi | Moderna - MRNA: Impfstoff-Aktie mit mega-starkem Comeback! | 655 | ratgeberGELD.at | + 100 Prozent in 6 Monaten! mrRNA-Impfstoffe gegen Krebs, Grippe & RSV bei Moderna in der Pipeline! Neue Rallye trotz US-Gesundheitsminister Robert F. Kennedy? Moderna (MRNA) - ISIN US60770K1079 Rückblick:... ► Artikel lesen | |
| MODERNA Aktie jetzt für 0€ handeln | |||||
| 08.04. | Moderna Is Most Shorted S&P 500 Stock Now. Is It a Contrarian Buy? | 64 | Barchart.com | ||
| 07.04. | Moderna, Inc.: Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 | 781 | ACCESS Newswire | CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | Shortseller-Radar: Auffällige Bewegungen bei Gerresheimer, Deutsche Börse und Evotec | 4investors | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert, unterliegt Transparenzpflichten gemäß EU-Leerverkaufsverordnung. Ab einer Netto-Leerverkaufsposition von 0,5 Prozent des ausgegebenen Aktienkapitals... ► Artikel lesen | |
| Do | Medincell to Host an Online R&D Day on Tuesday, May 12, 2026 | Business Wire | > From Science to Long-Term Value Creation
Regulatory News:
Medincell (Euronext Paris: MEDCL) will host an online R&D Day, held in English, on Tuesday, May 12, 2026, from 4:00 to 5:30 pm CEST... ► Artikel lesen | |
| Do | QIAGEN N.V.: QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026 | Business Wire | Highlights solutions addressing key oncology research needs across automated sample preparation, single-cell analysis, genomic profiling and data analysis QIAsymphony Connect will serve... ► Artikel lesen | |
| Do | Ainos Inc.: AI Nose Deployment in Hospital Infrastructure Marks Transition to Scalable Multi-Domain Platform | VASRO GmbH | VASRO's latest update on Ainos Inc. focuses on a new operational milestone that materially strengthens the company's platform thesis. Through a partnership with MacKay Memorial Hospital and Topco Scientific... ► Artikel lesen | |
| Do | Bio-Techne Corporation: Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity | PR Newswire | Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics.The... ► Artikel lesen |